MAX
Company Analysis Scopus Biopharma Inc
1. Summary
Advantages
- The stock's return over the last year (100%) is higher than the sector average (-6.17%).
- Current debt level 0% is below 100% and has decreased over 5 years from 115.69%.
Disadvantages
- Price (0.0006 $) is higher than fair price (0.00049 $)
- Dividends (0%) are below the sector average (8.04%).
- The company's current efficiency (ROE=0%) is lower than the sector average (ROE=17.17%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Scopus Biopharma Inc | Index | ||
|---|---|---|---|
| 7 days | 0% | 4% | -0.8% |
| 90 days | 50% | -0.2% | 3.2% |
| 1 year | 100% | -6.2% | 12.3% |
SCPS vs Sector: Scopus Biopharma Inc has outperformed the "" sector by 106.17% over the past year.
SCPS vs Market: Scopus Biopharma Inc has outperformed the market by 87.66% over the past year.
Stable price: SCPS is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: SCPS with weekly volatility of 1.92% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Above fair price: The current price (0.0006 $) is higher than the fair price (0.00049 $).
Price is higher than fair: The current price (0.0006 $) is 18.3% higher than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (21.21).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (47.13).
5.3. P/BV
P/BV vs Sector: The company's P/BV (0) is lower than that of the sector as a whole (7.09).
P/BV vs Market: The company's P/BV (0) is lower than that of the market as a whole (4.27).
5.5. P/S
P/S vs Sector: The company's P/S indicator (0) is lower than that of the sector as a whole (8.75).
P/S vs Market: The company's P/S indicator (0) is lower than that of the market as a whole (12.15).
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (0) is lower than that of the sector as a whole (177.42).
EV/Ebitda vs Market: The company's EV/Ebitda (0) is lower than that of the market as a whole (24.87).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -20% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-20%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (1006.39%).
6.4. ROE
ROE vs Sector: The company's ROE (0%) is lower than that of the sector as a whole (17.17%).
ROE vs Market: The company's ROE (0%) is lower than that of the market as a whole (50.34%).
6.6. ROA
ROA vs Sector: The company's ROA (0%) is lower than that of the sector as a whole (7.87%).
ROA vs Market: The company's ROA (0%) is lower than that of the market as a whole (35.3%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (46.45%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.86%).
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '8.04%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Based on sources: porti.ru
